The Cellular Immunotherapy for Cancer Working Committee provides scientific oversight for studies related to the utilization and outcomes after CAR-T Cell therapies and other cellular immunotherapies. Studies that focus on specific outcomes, predictors of outcomes, and utilization of CAR-T Cells should be submitted to this committee.
Studies and Publications
View planned, in progress, and completed studies and publications for this committee.
Meetings
CIBMTR Working Committees meet annually during the Tandem Meetings I Transplantation and Cellular Therapy Meetings of ASTCT & CIBMTR. View meeting materials for this committee.
For questions about this committee, or to get involved, please contact:
Committee Leadership
| Co-Chairs |
|---|
| Sarah Nikiforow, MD, PhD | Dana Farber Cancer Institute, Boston, MA |
| Peiman Hematti, MD | University of Wisconsin Hospital and Clinics, Madison, WI
|
Cameron Turtle, MBBS, PhD
| Fred Hutchinson Cancer Research Center, Seattle, WA
|
| assistant Scientific Director |
|---|
| Amy Moskop, MD, MS | Childrens' Wisconsin, Medical College of Wisconsin, CIBMTR MCW
|
| CIBMTR Statistician |
|---|
| Ben Jacobs, MS | Medical College of Wisconsin, CIBMTR MCW
|
